The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding d -Ala- d -Ala
Abstract
Vancomycin is an important drug for the treatment of Gram-positive bacterial infections. Resistance to vancomycin has begun to appear, posing a serious public health threat. Vancomycin analogs containing modified carbohydrates are very active against resistant microorganisms. Results presented here show that these carbohydrate derivatives operate by a different mechanism than vancomycin; moreover, peptide binding is not required for activity. It is proposed that carbohydrate-modified vancomycin compounds are effective against resistant bacteria because they interact directly with bacterial proteins involved in the transglycosylation step of cell wall biosynthesis. These results suggest new strategies for designing glycopeptide antibiotics that overcome bacterial resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Genetics and mechanisms of glycopeptide resistance in enterococci
Arthur, M., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1563 · Cited by 694
THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUP
Barna, J. C. J., & Williams, D. H. (1984) · Annual Review of Microbiology · doi:10.1146/annurev.mi.38.100184.002011 · Cited by 528
A Trivalent System from Vancomycin· d -Ala- d -Ala with Higher Affinity Than Avidin·Biotin
Rao, J., Lahiri, J., Isaacs, L., Weis, R. M., & Whitesides, G. M. (1998) · Science · doi:10.1126/science.280.5364.708 · Cited by 315
Specificity of combination between mucopeptide precursors and vancomycin or ristocetin
Perkins, H. R. (1969) · Biochemical Journal · doi:10.1042/bj1110195 · Cited by 279
Total Syntheses of Vancomycin and Eremomycin Aglycons
Evans, D. A., Wood, M. R., Trotter, B. W., Richardson, T. I., Barrow, J. C., & Katz, J. L. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981016)37:19<2700::aid-anie2700>3.0.co;2-p · Cited by 268
Biosynthesis of the peptidoglycan of bacterial cell walls
Anderson, J. S., Meadow, P. M., Haskin, M. A., & Strominger, J. L. (1966) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(66)90056-7 · Cited by 264
Bugg, T. D. H., Dutka-Malen, S., Arthur, M., Courvalin, P., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00222a002 · Cited by 223
Vancomycin Resistance: Decoding the Molecular Logic
Walsh, C. T. (1993) · Science · doi:10.1126/science.8392747 · Cited by 194
Production of hybrid glycopeptide antibiotics in vitro and in Streptomyces toyocaensis
Solenberg, P. J., Matsushima, P., Stack, D. R., et al. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90288-x · Cited by 169
Cited by
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Control of Cell Morphogenesis in Bacteria
Daniel, R. A., & Errington, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00421-5 · Cited by 740
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Self-citationJi, H., Li, X., & Zhang, H. (2009) · EMBO reports · doi:10.1038/embor.2009.12 · Cited by 636
Natural Products as Platforms To Overcome Antibiotic Resistance
Rossiter, S. E., Fletcher, M. H., & Wuest, W. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00283 · Cited by 622
Formation of the glycan chains in the synthesis of bacterial peptidoglycan
Heijenoort, J. V. (2001) · Glycobiology · doi:10.1093/glycob/11.3.25r · Cited by 526
Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones
Hooper, D. C. (2001) · Clinical Infectious Diseases · doi:10.1086/319370 · Cited by 517
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318535 · Cited by 369
Multi-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Self-citationAntibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Baran, A., Kwiatkowska, A., & Potocki, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065777 · Cited by 300
Mechanism of action of oritavancin and related glycopeptide antibiotics
Allen, N. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00144-4 · Cited by 276
Arthur, M. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.356 · Cited by 13
Metadata
- Authors
- Ge, M., Chen, Z., Russell, H., Onishi, Kohler, J., Silver, L. L., Kerns, R., Fukuzawa, S., Thompson, C., & Kahne, D.
- Venue
- Science
- Published
- 1999-04-16
- Volume
- 284
- Issue
- 5413
- Pages
- 507-511
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2139163666
- Cited by
- 318
- References
- 18
- FWCI
- 19.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.